(Q34996934)

English

Central nervous system effects of the interaction between risperidone (single dose) and the 5-HT6 antagonist SB742457 (repeated doses) in healthy men.

scientific article

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

5 August 2017

Central nervous system effects of the interaction between risperidone (single dose) and the 5-HT6 antagonist SB742457 (repeated doses) in healthy men. (English)

1 reference

Europe PubMed Central

PubMed publication ID

5 August 2017

1 reference

based on heuristic

inferred from title

author name string

Marieke Liem-Moolenaar

1

1 reference

Europe PubMed Central

PubMed publication ID

5 August 2017

Mandana Rad

2

1 reference

Europe PubMed Central

PubMed publication ID

5 August 2017

Stefano Zamuner

3

1 reference

Europe PubMed Central

PubMed publication ID

5 August 2017

Adam F Cohen

4

1 reference

Europe PubMed Central

PubMed publication ID

5 August 2017

Francesca Lemme

5

1 reference

Europe PubMed Central

PubMed publication ID

5 August 2017

Kari L Franson

6

1 reference

Europe PubMed Central

PubMed publication ID

5 August 2017

Joop M A van Gerven

7

1 reference

Europe PubMed Central

PubMed publication ID

5 August 2017

Emilio Merlo Pich

8

1 reference

Europe PubMed Central

PubMed publication ID

5 August 2017

language of work or name

0 references

publication date

1 June 2011

1 reference

Europe PubMed Central

PubMed publication ID

5 August 2017

British Journal of Clinical Pharmacology

1 reference

Europe PubMed Central

PubMed publication ID

5 August 2017

71

1 reference

Europe PubMed Central

PubMed publication ID

5 August 2017

6

1 reference

Europe PubMed Central

PubMed publication ID

5 August 2017

907-916

1 reference

Europe PubMed Central

PubMed publication ID

5 August 2017

The serotonin 5-HT6 receptor: a viable drug target for treating cognitive deficits in Alzheimer's disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3099377

8 July 2018

5-HT6 receptor antagonists as novel cognitive enhancing agents for Alzheimer's disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3099377

8 July 2018

Effect of intrapulmonary tetrahydrocannabinol administration in humans.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3099377

8 July 2018

5-HT6 receptor antagonist SB-399885 potentiates haloperidol and risperidone-induced dopamine efflux in the medial prefrontal cortex or hippocampus

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3099377

8 July 2018

Pharmacodynamic and pharmacokinetic effects of TPA023, a GABA(A) alpha(2,3) subtype-selective agonist, compared to lorazepam and placebo in healthy volunteers.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3099377

8 July 2018

SB-399885 is a potent, selective 5-HT6 receptor antagonist with cognitive enhancing properties in aged rat water maze and novel object recognition models.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3099377

8 July 2018

Negative signs and symptoms secondary to antipsychotics: a double-blind, randomized trial of a single dose of placebo, haloperidol, and risperidone in healthy volunteers

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3099377

8 July 2018

5-HT6 receptors: a novel target for cognitive enhancement

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3099377

8 July 2018

Biomarkers for the effects of selective serotonin reuptake inhibitors (SSRIs) in healthy subjects

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3099377

8 July 2018

Serotonin receptors represent highly favorable molecular targets for cognitive enhancement in schizophrenia and other disorders

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3099377

8 July 2018

Differences in the central nervous system distribution and pharmacology of the mouse 5-hydroxytryptamine-6 receptor compared with rat and human receptors investigated by radioligand binding, site-directed mutagenesis, and molecular modeling

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3099377

8 July 2018

Reversal of a cholinergic-induced deficit in a rodent model of recognition memory by the selective 5-HT6 receptor antagonist, Ro 04-6790.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3099377

8 July 2018

Higher-end serotonin receptors: 5-HT(5), 5-HT(6), and 5-HT(7).

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3099377

8 July 2018

Central nervous system effects of moxonidine experimental sustained release formulation in patients with mild to moderate essential hypertension.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3099377

8 July 2018

Influence of the 5-HT6 receptor on acetylcholine release in the cortex: pharmacological characterization of 4-(2-bromo-6-pyrrolidin-1-ylpyridine-4-sulfonyl)phenylamine, a potent and selective 5-HT6 receptor antagonist

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3099377

8 July 2018

Biomarkers for the effects of benzodiazepines in healthy volunteers

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3099377

8 July 2018

5-HT6 receptor binding sites in schizophrenia and following antipsychotic drug administration: autoradiographic studies with [125I]SB-258585.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3099377

8 July 2018

CNS effects of sumatriptan and rizatriptan in healthy female volunteers.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3099377

8 July 2018

Memories are made of this (perhaps): a review of serotonin 5-HT(6) receptor ligands and their biological functions

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3099377

8 July 2018

Concentration-effect relationships of two infusion rates of the imidazoline antihypertensive agent rilmenidine for blood pressure and development of side-effects in healthy subjects

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3099377

8 July 2018

Biomarkers for the effects of antipsychotic drugs in healthy volunteers

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3099377

8 July 2018

Characterization of SB-271046: a potent, selective and orally active 5-HT(6) receptor antagonist

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3099377

8 July 2018

Electroencephalographic and psychomotor effects of chlorpromazine and risperidone relative to placebo in normal healthy volunteers

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3099377

8 July 2018

Effects of clozapine and haloperidol on 5-HT6 receptor mRNA levels in rat brain

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3099377

8 July 2018

Effect of venlafaxine on the pharmacokinetics of risperidone.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3099377

8 July 2018

Involvement of 5-HT6 receptors in nigro-striatal function in rodents

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3099377

8 July 2018

Immuno-localization of serotonin 5-HT6 receptor-like material in the rat central nervous system

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3099377

8 July 2018

Determination of the role of the 5-ht6 receptor in the rat brain: a study using antisense oligonucleotides

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3099377

8 July 2018

Visual motor co-ordination and dynamic visual acuity

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3099377

8 July 2018

The action of sedatives on brain stem oculomotor systems in man

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3099377

8 July 2018

Lamotrigine (BW430C), a potential anticonvulsant. Effects on the central nervous system in comparison with phenytoin and diazepam

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3099377

8 July 2018

A comparison of the sensitivities of adaptive tracking, eye movement analysis and visual analog lines to the effects of incremental doses of temazepam in healthy volunteers

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3099377

8 July 2018

Delinquents and the Tapping Test

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3099377

8 July 2018

Effects of the 5-HT(6) receptor antagonist, SB-271046, in animal models for schizophrenia

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2125.2011.03902.X

21 January 2018

Neurocognitive effects of antipsychotic medications in patients with chronic schizophrenia in the CATIE Trial

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2125.2011.03902.X

21 January 2018

Pronounced cognitive deficits following an intravenous L-tryptophan challenge in first-degree relatives of bipolar patients compared to healthy controls

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2125.2011.03902.X

21 January 2018

Psychomotor and cognitive effects of a single oral dose of talnetant (SB223412) in healthy volunteers compared with placebo or haloperidol.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2125.2011.03902.X

21 January 2018

The sensitivity of pharmacodynamic tests for the central nervous system effects of drugs on the effects of sleep deprivation

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2125.2011.03902.X

21 January 2018

Saccadic peak velocity and EEG as end-points for a serotonergic challenge test.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2125.2011.03902.X

21 January 2018

Pharmacokinetic/pharmacodynamic assessment of tolerance to central nervous system effects of a 3 mg sustained release tablet of rilmenidine in hypertensive patients.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2125.2011.03902.X

21 January 2018

Pharmacokinetics, pharmacodynamics and the pharmacokinetic/ pharmacodynamic relationship of zolpidem in healthy subjects

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2125.2011.03902.X

21 January 2018

Psychedelic effects of ketamine in healthy volunteers: relationship to steady-state plasma concentrations

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2125.2011.03902.X

21 January 2018

Tryptophan depletion impairs memory consolidation but improves focussed attention in healthy young volunteers

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2125.2011.03902.X

21 January 2018

The effects of a glycine reuptake inhibitor R231857 on the central nervous system and on scopolamine-induced impairments in cognitive and psychomotor function in healthy subjects

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2125.2011.03902.X

21 January 2018

Effect of verapamil on pharmacokinetics and pharmacodynamics of risperidone: in vivo evidence of involvement of P-glycoprotein in risperidone disposition

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2125.2011.03902.X

21 January 2018

Effects of amisulpride, risperidone and chlorpromazine on auditory and visual latent inhibition, prepulse inhibition, executive function and eye movements in healthy volunteers

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2125.2011.03902.X

21 January 2018

Paradox lost? Exploring the role of alpha oscillations during externally vs. internally directed attention and the implications for idling and inhibition hypotheses.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2125.2011.03902.X

21 January 2018

SB-742457 and donepezil in Alzheimer disease: a randomized, placebo-controlled study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3099377

26 October 2018

A simple mechanical ataxia-meter

1 reference

https://pubmed.ncbi.nlm.nih.gov/21223356

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The pharmacokinetics of risperidone in humans: a summary

1 reference

https://pubmed.ncbi.nlm.nih.gov/21223356

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Metabolism of risperidone to 9-hydroxyrisperidone by human cytochromes P450 2D6 and 3A4

1 reference

https://pubmed.ncbi.nlm.nih.gov/21223356

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1111/J.1365-2125.2011.03902.X

1 reference

Europe PubMed Central

PubMed publication ID

5 August 2017

PMC publication ID

1 reference

Europe PubMed Central

PubMed publication ID

5 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

5 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34996934&oldid=1633531493"